ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 168 filers reported holding ZAI LAB LTD in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,851,004 | -8.1% | 240,683 | 0.0% | 1.74% | +29.7% |
| Q2 2023 | $6,366,065 | -20.5% | 240,683 | 0.0% | 1.34% | -50.1% |
| Q1 2023 | $8,005,117 | +8.6% | 240,683 | 0.0% | 2.69% | -3.8% |
| Q4 2022 | $7,372,120 | -12.7% | 240,683 | 0.0% | 2.80% | -8.9% |
| Q3 2022 | $8,443,000 | -2.0% | 240,683 | -3.1% | 3.07% | +7.5% |
| Q2 2022 | $8,613,000 | -13.6% | 248,357 | +9.5% | 2.85% | +29.4% |
| Q1 2022 | $9,973,000 | -31.2% | 226,752 | +4.6% | 2.20% | -23.3% |
| Q4 2021 | $14,505,000 | – | 216,752 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |